JP2024510930A5 - - Google Patents

Info

Publication number
JP2024510930A5
JP2024510930A5 JP2023553046A JP2023553046A JP2024510930A5 JP 2024510930 A5 JP2024510930 A5 JP 2024510930A5 JP 2023553046 A JP2023553046 A JP 2023553046A JP 2023553046 A JP2023553046 A JP 2023553046A JP 2024510930 A5 JP2024510930 A5 JP 2024510930A5
Authority
JP
Japan
Prior art keywords
treprostinyl
optionally substituted
salt
dried powder
powder formulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023553046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024510930A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/018505 external-priority patent/WO2022187352A1/en
Publication of JP2024510930A publication Critical patent/JP2024510930A/ja
Publication of JP2024510930A5 publication Critical patent/JP2024510930A5/ja
Pending legal-status Critical Current

Links

JP2023553046A 2021-03-03 2022-03-02 トレプロスチニル及びそのプロドラッグの乾燥粉末組成物、及び、さらに（ｅ）－３，６－ビス［４－（ｎ－カルボニル－２－プロペニル）アミドブチル］－２，５－ジケトピペラジン（ｆｄｋｐ）を含む乾燥粉末組成物 Pending JP2024510930A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163156110P 2021-03-03 2021-03-03
US63/156,110 2021-03-03
PCT/US2022/018505 WO2022187352A1 (en) 2021-03-03 2022-03-02 A dry powder composition of trestinil and its prodrug thereof and further comprising comprising (e)-3,6-bis[4-(n-carbonyl-2-propenyl)amidobutyl]-2,5-diketopiperazine (fdkp)

Publications (2)

Publication Number Publication Date
JP2024510930A JP2024510930A (ja) 2024-03-12
JP2024510930A5 true JP2024510930A5 (cg-RX-API-DMAC10.html) 2025-03-11

Family

ID=80930276

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023553046A Pending JP2024510930A (ja) 2021-03-03 2022-03-02 トレプロスチニル及びそのプロドラッグの乾燥粉末組成物、及び、さらに（ｅ）－３，６－ビス［４－（ｎ－カルボニル－２－プロペニル）アミドブチル］－２，５－ジケトピペラジン（ｆｄｋｐ）を含む乾燥粉末組成物

Country Status (9)

Country Link
US (2) US12168071B2 (cg-RX-API-DMAC10.html)
EP (1) EP4301372A1 (cg-RX-API-DMAC10.html)
JP (1) JP2024510930A (cg-RX-API-DMAC10.html)
KR (1) KR20240012354A (cg-RX-API-DMAC10.html)
CN (1) CN117479946A (cg-RX-API-DMAC10.html)
AU (1) AU2022229367A1 (cg-RX-API-DMAC10.html)
CA (1) CA3209987A1 (cg-RX-API-DMAC10.html)
IL (1) IL305510A (cg-RX-API-DMAC10.html)
WO (1) WO2022187352A1 (cg-RX-API-DMAC10.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119632930A (zh) 2019-04-29 2025-03-18 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
CN121241041A (zh) * 2023-01-19 2025-12-30 联合治疗公司 曲前列尼尔类似物及相关制备和使用方法
EP4680223A1 (en) * 2023-03-17 2026-01-21 Insmed Incorporated Spray dried treprostinil formulation
WO2025174856A1 (en) * 2024-02-12 2025-08-21 Mannkind Corporation Process for making a composition for pulmonary inhalation

Family Cites Families (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2485614A (en) 1946-08-29 1949-10-25 Chicago Bridge & Iron Co Stabilizing and guide apparatus for lifter roofs
US3037116A (en) 1957-07-26 1962-05-29 Weber Georges Apparatus for irradiating liquids
US3035516A (en) 1958-08-18 1962-05-22 Lee Brothers Company Stencil device
US3646509A (en) 1969-08-08 1972-02-29 Texas Instruments Inc Method for field stacking seismic data and system using write after read bulk data storage
US4306075A (en) 1980-03-28 1981-12-15 The Upjohn Company Composition and process
US4547016A (en) 1984-08-13 1985-10-15 Eeco Incorporated Quick release mounting
GB8814438D0 (en) 1988-06-17 1988-07-20 Wellcome Found Compounds for use in medicine
IT1231076B (it) 1989-09-28 1991-11-12 Pirelli Cavi Spa Procedimento per la realizzazione di gruppo di connessione separabile per fibre ottiche riunite a nastro e gruppo di connessione con esso realizzato.
GB9011588D0 (en) 1990-05-24 1990-07-11 Wellcome Found Prostaglandin analogues for use in medicine
US6441245B1 (en) 1997-10-24 2002-08-27 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
ES2214753T3 (es) 1997-11-14 2004-09-16 United Therapeutics Corporation Uso de 9-desoxi-2',9-alfa-metano-3-oxa-4,5,6-trinor-3,7-(1',3'-interfenilen)-13,14-dihidro-prostaglandina f1 para tratar la enfermedad vascular periferica.
US6521212B1 (en) 1999-03-18 2003-02-18 United Therapeutics Corporation Method for treating peripheral vascular disease by administering benzindene prostaglandins by inhalation
KR20020012169A (ko) 1999-03-31 2002-02-15 유나이티드 쎄러퓨틱스 코포레이션 프로스타글란딘 화합물, 조성물 및 말초혈관질병 및폐고혈압증의 치료방법
US7464706B2 (en) 1999-07-23 2008-12-16 Mannkind Corporation Unit dose cartridge and dry powder inhaler
US7305986B1 (en) 1999-07-23 2007-12-11 Mannkind Corporation Unit dose capsules for use in a dry powder inhaler
US6700025B2 (en) 2001-01-05 2004-03-02 United Therapeutics Corporation Process for stereoselective synthesis of prostacyclin derivatives
US6803386B2 (en) 2002-01-16 2004-10-12 United Therapeutics Corporation Prostacyclin derivative containing compositions and methods of using the same for the treatment of cancer
US6756117B1 (en) 2002-12-20 2004-06-29 The United States Of America As Represented By The United States Department Of Energy Photonic polymer-blend structures and method for making
CN102697790A (zh) 2003-05-22 2012-10-03 联合治疗公司 化合物和释放前列环素类似物的方法
US20090124697A1 (en) 2003-12-16 2009-05-14 United Therapeutics Corporation Inhalation formulations of treprostinil
US7199157B2 (en) 2003-12-16 2007-04-03 United Therapeutics Corporation Use of treprostinil to improve kidney functions
CN1917866B (zh) 2003-12-16 2010-12-15 联合治疗公司 曲前列环素或它的衍生物，或其药学上可接受的盐在制备治疗和预防缺血性损害的药物中的用途
DE602005020269D1 (de) 2004-04-12 2010-05-12 United Therapeutics Corp Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
US8747897B2 (en) 2006-04-27 2014-06-10 Supernus Pharmaceuticals, Inc. Osmotic drug delivery system
CA2654492C (en) 2006-05-15 2017-06-27 United Therapeutics Corporation Treprostinil administration using a metered dose inhaler
US20090036465A1 (en) 2006-10-18 2009-02-05 United Therapeutics Corporation Combination therapy for pulmonary arterial hypertension
CA2678258A1 (en) 2007-02-09 2008-08-14 United Therapeutics Corporation Treprostinil treatment for interstitial lung disease and asthma
CN103181893A (zh) 2007-09-07 2013-07-03 联合治疗公司 针对革兰氏阴性细菌具有选择性杀菌活性的缓冲液及其使用方法
WO2009078965A1 (en) 2007-12-17 2009-06-25 United Therapeutics Corporation An improved process to prepare treprostinil, the active ingredient in remodulin
JP6219016B2 (ja) 2008-05-08 2017-10-25 ユナイテッド セラピューティクス コーポレーション トレプロスチニル一水和物
MY155524A (en) 2008-06-13 2015-10-30 Mannkind Corp A dry powder inhaler and system for drug delivery
CN102421288B (zh) 2009-05-07 2015-04-22 联合治疗公司 前列环素类似物的固体剂型
AU2010280684B2 (en) 2009-08-07 2016-07-28 Scipharm Sarl Composition for the treatment of cystic fibrosis
KR20160132501A (ko) 2010-03-15 2016-11-18 유나이티드 세러퓨틱스 코오포레이션 폐고혈압의 치료
CN103261142B (zh) 2010-06-03 2014-12-10 联合治疗公司 曲前列环素的制备
CA2710725C (en) 2010-07-22 2017-08-01 Alphora Research Inc. Protected aldehydes for use as intermediates in chemical syntheses, and processes for their preparation
CA2710726C (en) 2010-07-22 2016-02-23 Alphora Research Inc. Synthesis of treprostinil and intermediates useful therein
CA2726599C (en) 2010-12-30 2017-07-25 Alphora Research Inc. Process for treprostinil salt preparation
ES2581762T3 (es) 2011-03-02 2016-09-07 United Therapeutics Corporation Síntesis de producto intermedio para la producción de treprostinil
US9388154B2 (en) 2011-09-12 2016-07-12 Lund Biotechnology PBC Process for preparing synthetic prostacyclins
CN103193626B (zh) 2012-01-10 2016-05-11 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
CN103193627B (zh) 2012-01-10 2016-04-20 上海天伟生物制药有限公司 一种前列腺素类似物的晶型及其制备方法和用途
US9387214B2 (en) 2012-01-13 2016-07-12 United Therapeutics Corporation Method of identifying therapies for pulmonary hypertension
SI2674413T1 (sl) 2012-06-15 2017-10-30 Scipharm Sarl Postopek za pripravo treprostinila in derivatov le-tega
WO2014085813A1 (en) 2012-11-30 2014-06-05 Insmed Incorporated Prostacylin compositions and methods for using the same
CN104837806A (zh) 2012-12-07 2015-08-12 开曼化学股份有限公司 前列环素类似物的合成方法
EP3712142B1 (en) 2013-01-11 2022-07-06 Corsair Pharma, Inc. Prodrugs of treprostinil
US9505737B2 (en) 2013-01-11 2016-11-29 Corsair Pharma, Inc. Treprostinil derivative compounds and methods of using same
WO2014159050A1 (en) 2013-03-14 2014-10-02 United Therapeutics Corporation Solid forms of treprostinil
EP2970081A4 (en) 2013-03-15 2016-10-12 United Therapeutics Corp SALTS OF TREPROSTINIL
CA2911172C (en) 2013-04-30 2021-10-19 United Therapeutics Corporation Controlled release pharmaceutical formulations
WO2014203278A2 (en) * 2013-06-19 2014-12-24 Msn Laboratories Private Limited NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
US9469600B2 (en) 2013-10-25 2016-10-18 Insmed Incorporated Prostacyclin compounds, compositions and methods of use thereof
JP2016538161A (ja) 2013-11-27 2016-12-08 コーニング インコーポレイテッド 基板の改善された製造のための組成
TWI685348B (zh) 2014-05-08 2020-02-21 美國禮來大藥廠 速效胰島素組合物
WO2015174197A1 (ja) 2014-05-14 2015-11-19 富士電機株式会社 半導体装置および半導体装置の製造方法
ES2908142T3 (es) 2014-06-13 2022-04-27 United Therapeutics Corp Formulaciones de treprostinil
US20160045470A1 (en) 2014-08-12 2016-02-18 Dr. Reddy's Laboratories Limited Amorphous solid dispersion of treprostinil diethanolamine
WO2016038532A1 (en) 2014-09-09 2016-03-17 Mylan Laboratories Limited Amorphous treprostinil diethanolamine
HU231184B1 (hu) 2014-10-08 2021-07-28 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
CN107108427A (zh) 2014-10-20 2017-08-29 联合治疗学有限公司 用于制备前列环素衍生物的中间体的合成
US10343979B2 (en) 2014-11-18 2019-07-09 Insmed Incorporated Methods of manufacturing treprostinil and treprostinil derivative prodrugs
TWI540121B (zh) 2014-12-01 2016-07-01 臺灣永光化學工業股份有限公司 曲前列環素二乙醇胺之合成方法及新穎中間體
WO2016105538A1 (en) 2014-12-23 2016-06-30 Sandia Corporation Sandia National Laboratories Adjusting the ph of a pretreatment solution using carbon dioxide useful for integrating saccharification and fermentation
US20160243064A1 (en) * 2015-02-21 2016-08-25 Gavis Pharmaceuticals Novel oral pharmaceutical compositions of treprostinil
US9643911B2 (en) 2015-06-17 2017-05-09 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US9394227B1 (en) 2015-06-17 2016-07-19 Corsair Pharma, Inc. Treprostinil derivatives and compositions and uses thereof
US20190321290A1 (en) 2016-01-29 2019-10-24 Mannkind Corporation Composition and method for inhalation
IL260823B2 (en) * 2016-01-29 2024-08-01 Mannkind Corp Dry powder inhaler
KR20180133401A (ko) 2016-04-08 2018-12-14 이데미쓰 고산 가부시키가이샤 전기 화학 소자용 바인더
WO2018058124A1 (en) 2016-09-26 2018-03-29 United Therapeutics Corporation Treprostinil prodrugs
CA3102967A1 (en) * 2018-06-07 2019-12-12 Mannkind Corporation Composition and method for inhalation
CN119632930A (zh) 2019-04-29 2025-03-18 英斯梅德股份有限公司 曲前列素前药的干粉组合物及其使用方法
CN114616225A (zh) * 2019-08-23 2022-06-10 联合治疗公司 曲前列环素前药
IL296567A (en) 2020-04-17 2022-11-01 United Therapeutics Corp Terfostinil for use in the treatment of interstitial lung disease
AU2021289336B2 (en) 2020-06-09 2025-08-28 Mannkind Corporation Fumaryl diketopiperidine prodrugs of treprostinil

Similar Documents

Publication Publication Date Title
JP2024504932A5 (cg-RX-API-DMAC10.html)
CN105051051A (zh) 用于合成神经鞘磷脂和二氢神经鞘磷脂的方法
US6638919B2 (en) Antiviral purine derivatives
JP2021534279A5 (cg-RX-API-DMAC10.html)
RU2223262C2 (ru) Новые ацилированные псевдодипептиды, способ их получения и содержащие их фармацевтические композиции
US9708354B2 (en) Methods for the synthesis of sphingomyelins and dihydrosphingomyelins
RU2010101611A (ru) Полициклические производные гуанина и способы их применения
JP2007512359A5 (cg-RX-API-DMAC10.html)
RU2379295C2 (ru) Производные пиридазинона в качестве агонистов рецептора тиреоидного гормона
RU2001102614A (ru) Новые ацилированные псевдодипептиды, способ их получения и содержащие их фармацевтические композиции
Prishchenko et al. Synthesis of new organophosphorus‐substituted derivatives of functionalized propionates and their analogues
RU2004129584A (ru) Производное 8-азапростагландина и агент, содержащий данное соединение в качестве активного ингредиента
RU2015104031A (ru) Некоторые аминоалкилглюкозаминидфосфатные производные и их применение
JP2013010784A (ja) ホスホン酸含有歯科材料
JP5630999B2 (ja) 歯科用接着剤組成物
RU2006101987A (ru) Трициклические производные или их фармацевтически приемлемые соли, способы их получения и содержащие их фармацевтические композиции
CA2711141C (fr) Derives d'acide hydroxy-bisphosphonique comme vecteur ciblant le tissu osseux
JP2014527969A5 (cg-RX-API-DMAC10.html)
JP2023520201A5 (cg-RX-API-DMAC10.html)
CN117479946A (zh) 含曲前列环素及其前药并还包含(e)-3,6-双[4-(n-羰基-2-丙烯基)酰胺丁基]-2,5-二酮哌嗪(fdkp)的干粉组合物
JPH05500949A (ja) ｇｅｍ―ジホスホン酸、その製造法、およびそれを含む医薬組成物
JP2011529023A5 (cg-RX-API-DMAC10.html)
JPH069668A (ja) アリールおよびヘテロアリール（ホスフィニルメチル）ホスホネートスクアレンシンセターゼ抑制剤
BG62775B1 (bg) Метод за получаване на азамакроциклични или ациклични аминофосфонатни естерни производни
PT767794E (pt) Derivados do acido fosfinico